|
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016 open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15 |
Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter
Copyright Infringement Claims
Indexing Partner
|
Published Paper Details
|
|
| Paper Title: | STUDY OF MUCORMYCOSIS IN COVID AND POST COVID PATIENTS FROM A TERTIARY CARE HOSPITAL IN CENTRAL INDIA |
| Authors Name: | Dr. Sunita Raj Gajbhiye , Dr. Nirmal Manohar Channe , Dr. Bhawana P. Bajare , Dr S.S. Zodpey (Shrikhande) |
| Unique Id: | IJSDR2301153 |
| Published In: | Volume 8 Issue 1, January-2023 |
| Abstract: | Introduction: The pandemic corona virus disease 2019(covid19) continues to be a significant problem worldwide. The opportunistic fungal infections particularly mucormycosis in the shadow of poorly controlled diabetes mellitus and inadvertent use of corticosteroids are emerging as matter of concern in covid19 patients. As there are very few studies available on the recent epidemic of mucormycosis, the study on epidemiology and mycological aspect of mucormycosis in patients infected with covid19 infection was undertaken. Objective: To isolate and identify different fungi causing mucormycosis in covid and post covid patients and to study the risk factors associated with post-covid mucormycosis. Material and Methods: Relevant clinical samples from cases of mucormycosis were received in mycology section of department of microbiology were processed by standard conventional methods.Results: Out of total 634 samples received, majority samples were from males with male: female ratio of 2.2:1. Various risk factors associated with covid19 infections and mucormycosis were diabetes mellitus in 72%, inadvertent use of corticosteroids in68%, hypertension in 62% and respiratory illnesses in 45%cases. Out of total 634 samples, 154(24.29%) were culture positive. Of these, Mucor was grown in 29.87% cases followed by Aspergillus in 23.37% and Candida in 25.97% cases. We also isolated Rhizopus spp. (10.38%), Schizophyllum spp. (6.49%) and Fusarium spp. (3.89%).Conclusion: This study helped us to know about various fungi and risk factors associated with mucormycosis in covid and post-covid patients. The timely diagnosis and high index of suspicion is required to manage and treat mucormycosis in post-covid patients. |
| Keywords: | Covid19, Post-covid,Mucormycosis, Risk factors |
| Cite Article: | "STUDY OF MUCORMYCOSIS IN COVID AND POST COVID PATIENTS FROM A TERTIARY CARE HOSPITAL IN CENTRAL INDIA", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.8, Issue 1, page no.964 - 969, January-2023, Available :http://www.ijsdr.org/papers/IJSDR2301153.pdf |
| Downloads: | 000337072 |
| Publication Details: | Published Paper ID: IJSDR2301153 Registration ID:203690 Published In: Volume 8 Issue 1, January-2023 DOI (Digital Object Identifier): Page No: 964 - 969 Publisher: IJSDR | www.ijsdr.org ISSN Number: 2455-2631 |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijsdr.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
Track Paper
Important Links
Conference Proposal
ISSN
 |
 |
DOI (A digital object identifier)
  Providing A digital object identifier by DOI How to GET DOI and Hard Copy Related |
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
 |
 |
 |
Social Media
Indexing Partner |
|||
| Copyright © 2024 - All Rights Reserved - IJSDR | |||
Facebook Twitter Instagram LinkedIn